In a balanced , crossover design ( with a 4-day washout between treatments ) , 12 subjects received one 400 mg film-coated tablet ( fasted ) , four 100 mg EC tablets ( fasted ) , one 400 mg GFS dose ( fasted ) and four 100 mg EC tablets ( after a high-fat meal ) .